Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IRWD · against 1,372 other Healthcare companies
Ranked #1,148 of 1,373 · scores higher than 16% of peers · safety percentile 16
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including IRWD · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | IRWD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | Not reported | 0.24× | — | — | 33% |
| BetaLower is better · 1,320 reported | 0.22 | 0.53 | 76% | 33% | |
| Current ratioHigher is better · 1,338 reported | 6.06× | 2.62× | 79% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,144 | 1.18T KRW (≈$847M) | 17 | 63 | |
| 1,145 | 913M HKD (≈$117M) | 17 | 43 | |
| 1,146 | 595M USD | 17 | 29 | |
| 1,147 | 1.3B USD | 16 | 33 | |
| 1,148 | 578M USD | 16 | 73 | |
| 1,149 | 29.0B JPY (≈$197M) | 16 | 56 | |
| 1,150 | 243M USD | 16 | 56 | |
| 1,151 | 105.7B KRW (≈$76M) | 16 | 37 | |
| 1,152 | 2.7B USD | 16 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score